DiaMedica Therapeutics (DMAC)

• Market cap: $243M
• 1 day: -1.90%
• 5 days: -3.72%
• 1 month: -8.96%
• 3 months: 5.76%
• 6 months: 26.44%
• Year to date: 3.27%
• 1 year: 96.21%
• 5 years: 58.06%
• 10 years: 83.55%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Employees: 19

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

4,300% more call options, than puts

Call options by funds: $264K | Put options by funds: $6K

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

57% more capital invested

Capital invested by funds: $23.3M [Q3] → $36.5M (+$13.2M) [Q4]

13% more funds holding

Funds holding: 40 [Q3] → 45 (+5) [Q4]

2.68% more ownership

Funds ownership: 13.05% [Q3] → 15.74% (+2.68%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]